16 In addition, colistin–meropenem combination or other regimens did not result in better outcomes compared with colistin monotherapy because CRAB isolates are almost significantly higher MICs of meropenem (higher than 8 μg/mL), so it is unlikely to offer the advantage of colistin–meropenem combination therapy. 17 Difficulties in treating CRAB infections still challenge physicians in optimizing antibiotic therapy in the setting of highly resistant pathogens.
← all excerpts
Epidemiology, Clinical Characteristics and Treatment Outcomes of <i>Acinetobacter baumannii</i> Infection at a Regional Hospital in Thailand.
1
—
—